Menu Search
Equities

Nephros Inc

NPJP:DEU

Nephros Inc

Actions
  • Price (EUR)1.58
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Nephros Inc grew revenues 42.74% from 9.98m to 14.24m while net income improved from a loss of 7.38m to a smaller loss of 1.58m.
Gross margin60.38%
Net profit margin-9.40%
Operating margin-9.94%
Return on assets-12.05%
Return on equity-15.61%
Return on investment-14.11%
More ▼

Cash flow in USDView more

In 2023, Nephros Inc increased its cash reserves by 18.52%, or 673.00k. The company earned 827.00k from its operations for a Cash Flow Margin of 5.81%. In addition the company used 75.00k on investing activities and also paid 79.00k in financing cash flows.
Cash flow per share-0.1066
Price/Cash flow per share--
Book value per share0.7517
Tangible book value per share0.622
More ▼

Balance sheet in USDView more

Nephros Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio4.06
Quick ratio2.62
Total debt/total equity0.0001
Total debt/total capital0.0001
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.